wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q28247445-D02C4F38-6459-4AD2-BEA8-DCA8865261E6
Q28247445-D02C4F38-6459-4AD2-BEA8-DCA8865261E6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28247445-D02C4F38-6459-4AD2-BEA8-DCA8865261E6
A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density
P2860
Q28247445-D02C4F38-6459-4AD2-BEA8-DCA8865261E6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28247445-D02C4F38-6459-4AD2-BEA8-DCA8865261E6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5c5336ec1c6cb64a2fc78e4d3c11f56c59a20cb7
P2860
Sclerostin: therapeutic horizons based upon its actions.